97 related articles for article (PubMed ID: 2785851)
1. Purification and characterization of tumor inhibitory factor-2: its identity to interleukin 1.
Fryling C; Dombalagian M; Burgess W; Hollander N; Schreiber AB; Haimovich J
Cancer Res; 1989 Jun; 49(12):3333-7. PubMed ID: 2785851
[TBL] [Abstract][Full Text] [Related]
2. Purification and some properties of a lung-derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung.
Cavanaugh PG; Nicolson GL
Cancer Res; 1989 Jul; 49(14):3928-33. PubMed ID: 2544264
[TBL] [Abstract][Full Text] [Related]
3. Human growth factor for murine interleukin (IL)-9 responsive T cell lines: co-induction with IL-6 in fibroblasts and identification as LIF/HILDA.
Van Damme J; Uyttenhove C; Houssiau F; Put W; Proost P; Van Snick J
Eur J Immunol; 1992 Nov; 22(11):2801-8. PubMed ID: 1425908
[TBL] [Abstract][Full Text] [Related]
4. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
5. Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
Iwata KK; Fryling CM; Knott WB; Todaro GJ
Cancer Res; 1985 Jun; 45(6):2689-94. PubMed ID: 3857121
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha.
Sasaki M; Kashima M; Ito T; Watanabe A; Izumiyama N; Sano M; Kagaya M; Shioya T; Miura M
Mediators Inflamm; 2000; 9(3-4):155-60. PubMed ID: 11132772
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell proliferation by interleukin-1 derived from monocytic leukemia cells.
Tsai SC; Gaffney EV
Cancer Res; 1986 Mar; 46(3):1471-7. PubMed ID: 3484681
[TBL] [Abstract][Full Text] [Related]
8. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.
Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ
J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146
[TBL] [Abstract][Full Text] [Related]
10. Purification to homogeneity and NH2-terminal amino acid sequence of a novel interleukin 1 species derived from a human B cell line.
Rimsky L; Wakasugi H; Ferrara P; Robin P; Capdevielle J; Tursz T; Fradelizi D; Bertoglio J
J Immunol; 1986 May; 136(9):3304-10. PubMed ID: 3485686
[TBL] [Abstract][Full Text] [Related]
11. A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.
Seckinger P; Williamson K; Balavoine JF; Mach B; Mazzei G; Shaw A; Dayer JM
J Immunol; 1987 Sep; 139(5):1541-5. PubMed ID: 3040855
[TBL] [Abstract][Full Text] [Related]
12. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression.
Rak JW; Hegmann EJ; Lu C; Kerbel RS
J Cell Physiol; 1994 May; 159(2):245-55. PubMed ID: 8163565
[TBL] [Abstract][Full Text] [Related]
13. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor.
Endo Y; Matsushima K; Onozaki K; Oppenheim JJ
J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724
[TBL] [Abstract][Full Text] [Related]
14. IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta.
Sandborg CI; Imfeld KL; Zaldivar F; Wang Z; Buckingham BA; Berman MA
J Immunol; 1995 Dec; 155(11):5206-12. PubMed ID: 7594531
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of a unique human interleukin 1 from the tumor cell line U937.
Knudsen PJ; Dinarello CA; Strom TB
J Immunol; 1986 May; 136(9):3311-6. PubMed ID: 3485687
[TBL] [Abstract][Full Text] [Related]
16. Constitutive production by the WEHI-3 cell line of B cell growth and differentiation factor that co-purifies with interleukin 1.
Booth RJ; Prestidge RL; Watson JD
J Immunol; 1983 Sep; 131(3):1289-93. PubMed ID: 6604093
[TBL] [Abstract][Full Text] [Related]
17. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
García-Vázquez MD; Boyano MD; Cañavate ML; Gardeazabal J; de Galdeano AG; López-Michelena T; Ratón JA; Izu R; Díaz-Ramón JL; Díaz-Pérez JL
Eur Cytokine Netw; 2000 Dec; 11(4):654-61. PubMed ID: 11125310
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a novel transforming growth factor.
Halper J; Moses HL
Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
[TBL] [Abstract][Full Text] [Related]
20. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
